Congratulations Ashkan Shoamanesh !! 🎉🥂

Drs. Aristeidis Katsanos and Ashkan Shoamanesh of McMaster University are leading the CoVasc-ICH study to see if colchicine, a drug that reduces inflammation and clotting, can lower the risk of blood clots, heart attacks, or stroke in hemorrhagic stroke survivors. bit.ly/3WB2J5o?hsid=9…

Thanks to CIHR the idea for CoVasc-ICH became a reality, and now is growing from a phase 2 study to an international phase 3 trial! McMaster Stroke Program McMaster University Department of Medicine PHRI.ca Population Health Research Institute 🇨🇦

Thank you Bishal Gyawali, MD, PhD, FASCO and @Claudia_Editor for the opportunity. Hopefully this paper would be a good resource for anyone interested in reading about surrogate end points in oncology! Brooke Wilson Common Sense Oncology Health Sciences North / Horizon Santé-Nord NOSM University | Université EMNO

We need to OPTIMISE further the referral pathways for EVT patients, by reducing door in/ door out times in primary stroke centres PHRI.ca Population Health Research Institute 🇨🇦 McMaster University Department of Medicine McMaster Stroke Program

Congratulations to Abdulrahman Alrasheed for becoming the 31st McMaster Stroke Fellowship graduate and first recipient of the Excellent in study Recruitment Award! Kudos!

Congratulations to the ENRICH AF team #PHRI for completing enrolment of a trial that has become the largest RCT in ICH patients 👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏👏 Ashkan Shoamanesh

Congratulations to #PHRI Investigator Raed Joundi and Scientist William McIntyre (William F McIntyre) on receiving the Heart & Stroke New Investigator Award 2024/25!🎉 Read more: phri.ca/heartstrokeawa… #PHRIResearch #ResearchExcellence McMaster Health Sciences McMaster University Department of Medicine Hamilton Health Sciences

McMaster stroke out for dinner with our cherished colleagues visiting from Boston (Dr Lioutas) and Ottawa (Dr Dowlatshahi).

Congrats Dr Joundi!

CAD Infographic ahajournals.org/doi/full/10.11…)%20can%20cause%20permanent%20injury. #SVIN24 Stroke: Vascular and Interventional Neurology SVIN Alexandra Czap Luciano Sposato 🇦🇷🇨🇦 Jay Dolia MD Jay Kinariwala Dinesh Jillella, MD Sitara Koneru, MD Mikayel Grigoryan Nirav Bhatt Diogo Haussen Vera Sharashidze Fatima Khalid, MD فاطمہ

Super proud of #PHRI Investigators Raed Joundi, Aristeidis Katsanos (Aristeidis Katsanos), Rachel Eikelboom (Rachel Eikelboom), & Scientist Marie Pigeyre for receiving the Heart & Stroke Grant-in-Aid 2024/2025!🎉 Congrats! Read more about their research phri.ca/heartstrokegia/ McMaster University Department of Medicine

Should patients with #stroke and device-detected subclinical #AFib (SCAF) receive OAC? Our subgroup analyses of the The ARTESiA Trial 🇨🇦 published in The Lancet Neurology provide novel insights indicating that they indeed should in the right setting. thelancet.com/journals/laneu… #CardioTwitter

Day 1 #ISC25 International Stroke Conference. It is a very exciting day, and three major MeVo DMVO trial results are presented. At this time, no benefit has been observed with EVT in MeVo or DMVO #Stroke #Neurology #neurotwitter #Stroketwitter Canadian Stroke Consortium

Day 3 #ISC2025 Congratulations to all the Investigators and their teams for all the hard work #stroke American_Stroke : a)PRESTIGE-AF (NNT13 and NNH 24), b) Microcirculation: IA TNK or tPA beneficial without increased sICH, c) IVT>4.5h tPA in CTP selected AIS beneficial

Congratulations Aristeidis Katsanos and Ashkan Shoamanesh!! True Rockstars!!

Major congrats to Aristeidis Katsanos for being selected to receive the Michael Pessin Stroke leadership award at #AAN2025 Great work and look forward to your future contributions! Ashkan Shoamanesh Canadian Stroke Consortium World Stroke Org

Day 1 #ESOC2025 Canadian Stroke Consortium European Stroke Org Happening day, bridging with TNK and EVT is better, low intensity monitoring after IVT is safe, tirofiban post IVT may be helpful, and prolonged anticoagulation is not helpful in CVST.

1) Welcome to a new #accredited #tweetorial from @cardiomet_ce! This tweetorial is the first of 3⃣ that will address advances in the secondary prevention of ischemic, non-cardioembolic #stroke #SSP. Follow this 🧵for 0.5hr 🆓 CE/#CME !